30 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
machine readable or otherwise, and (iii) all documentation, training materials and configurations related to any of the foregoing (collectively
8-K
EX-2.1
exa2n629nwjeghx
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
fhn0heluj3j7ijhr pqm
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
f3p 3iuxts
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
fvyme
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
8-K
ypxa5y2e2m8qr yb1
7 Feb 22
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.1
xuz2r1ndw
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am